Articles by AJKDblog

The Future of Hepatitis C and Kidney Transplantation

August 17, 2017 // 0 Comments

This is Part 2 of a 2-part series on Hepatitis C and kidney transplantation. Part 1 reviewed the history of HCV, the era of IFN therapy, and the use of DAAs in patients with advanced CKD. The Future Now that we think we can reliably and safely [read more...]

Hepatitis C and Kidney Transplantation: Past, Present, and Future

August 14, 2017 // 1 Comment

This is Part 1 of a 2-part series on Hepatitis C and kidney transplantation, highlighting some of the exciting breakthroughs impacting this field that have come about as a result of promising antiretroviral therapy. Part 1: Hepatitis C and Kidney [read more...]

The Uncertainty Over Treatment Options for Uremic Pruritus

August 9, 2017 // 0 Comments

A recent article in AJKD by Simonsen et al (Open Access) describes a systematic review of treatment options for uremic pruritis, a debilitating condition in patients with end-stage renal disease (ESRD) and an identified priority for renal research [read more...]

Increasing Familiarity with Nephrology Among Internal Medicine Interns

August 4, 2017 // 0 Comments

Nephrology is currently undergoing a renaissance in education. These are exciting times to be involved in nephrology. We are beginning to see multiple stakeholders invest in education at both the local and national level. Clinicians, researchers, [read more...]

Improving Late-Stage CKD Care

August 1, 2017 // 0 Comments

Advanced chronic kidney disease (CKD) planning to prep for renal replacement therapies, subsequent access planning, and preemptive transplant can be overwhelming. Data suggests that outcomes for patients with advanced CKD stages 4 to 5 in the United [read more...]

KDIGO CKD-MBD Updated Guideline: The More We Know, The Less We Know

July 27, 2017 // 0 Comments

The KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update was released last month. The team at KDIGO, as usual, did a great job presenting the update for people with differing needs and goals. The guideline update [read more...]

Pruning Polypharmacy: Pill Pushers to Deprescribers in Dialysis?

July 20, 2017 // 1 Comment

The Causes and Consequences of Polypharmacy When faced with a patient who has a symptom, or a clinical or even laboratory abnormality, the natural tendency for a physician is to prescribe something, anything, in a genuine effort to alleviate the [read more...]

Nodular Glomerulosclerosis – Not All Are Created Equal

July 18, 2017 // 0 Comments

PathPointers is a new type of blog post that will highlight important everyday teaching points when reviewing kidney histology. These blog posts will be brief and easy-to-read, using real clinical images to demonstrate various biopsy findings. In [read more...]

Impact of Maternal Unilateral Renal Agenesis on Pregnancy

July 14, 2017 // 1 Comment

Unilateral renal agenesis has an incidence of 1:2,300 individuals. Patients with unilateral renal agenesis are at increased risk for development of proteinuria, hypertension, and renal insufficiency. A recent systematic review found that 10% of [read more...]

Management of Gout in the CKD Patient…Not So Different After All!

July 11, 2017 // 0 Comments

One afternoon during my year as Chief Resident, I was asked to cover the resident Clinic at our Veteran’s Affairs (VA) hospital. One of the senior residents presented a patient who had stage 4 CKD. Several weeks prior, he had been treated through [read more...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases